Valteau-Couanet, Dominique <br/><br/>
Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.  [electronic resource] 

 -  Pediatric blood & cancer  Jun 2014 
 - 977-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.24713  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abdominal Neoplasms--drug therapy<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Busulfan--administration & dosage<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Consolidation Chemotherapy<br/>Disease-Free Survival<br/>Follow-Up Studies<br/>Gene Amplification<br/>Genes, myc<br/>Hematopoietic Stem Cell Transplantation<br/>Hepatic Veno-Occlusive Disease--chemically induced<br/>Humans<br/>Infant<br/>Kaplan-Meier Estimate<br/>Melphalan--administration & dosage<br/>Myeloablative Agonists--therapeutic use<br/>Neuroblastoma--drug therapy<br/>Proportional Hazards Models<br/>Remission Induction<br/>Thoracic Neoplasms--drug therapy<br/>Transplantation Conditioning<br/>Transplantation, Autologous<br/>Treatment Outcome